# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001144204-18-020307
Filing Date
2018-04-12
Accepted
2018-04-12 16:46:32
Documents
3
Period of Report
2018-05-31
Effectiveness Date
2018-04-12

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | tv490450-def14a.htm | DEF 14A | 592617
2 | GRAPHIC | tv490450_pc-pg01.jpg | GRAPHIC | 259249
3 | GRAPHIC | tv490450_pc-pg02.jpg | GRAPHIC | 271802
| Complete submission text file | 0001144204-18-020307.txt |  | 1308567

Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

EIN.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-50626 | Film No.: 18752518
SIC: 2834 Pharmaceutical Preparations